Received Dec 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | Z007847 | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z005055 | — |
No symptoms reported; received his second dose of GARDASIL 9 late; This spontaneous report was received from medical assistant referring to a 43 -year-old male patient. The patient's medical history, previous drug reactions or allergies and concomitant medications were not reported. On 24-Jul-2025, the patient was vaccinated with first dose of GARDASIL 9 injection at a dose of 0.50 mL for prophylaxis (strength, route of administration, and anatomical location were not reported; lot Number: Z005055 has been verified to be a valid, expiration date: 27-Feb-2026). It was reported the patient received his second dose of GARDASIL 9 at a dose of 0.50 mL for prophylaxis (strength, route of administration, and anatomical location were not reported; lot Number: Z007847 has been verified to be a valid, expiration date: 05-Mar-2026) late on 24-Nov-2025. No symptoms reported.